A M Lever|S D Griffin - JoVE Visualize

Showing results (51-60 of 64) with videos related to

Pageof 7

Sort By:

Clinical and Experimental Immunology|February 1, 1987

Increased half-life of gammaglobulin after prolonged intravenous replacement therapyA M Lever, P L Yap, B Cuthbertson, et al.

Infection|January 1, 1987

A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies of hepatitis B virus carrier treatment: identification of factors influencing response ratesH C Thomas, L J Scully, A M Lever, et al.

Journal of Virological Methods|April 20, 2001

Chromosomal positioning of human T-lymphotropic type 1 proviruses by fluorescence in situ hybridisationJ H Richardson, N J Rose, S Mann, et al.

Virology|September 7, 2001

Sequences in the 5' leader of Mason-Pfizer monkey virus which affect viral particle production and genomic RNA packaging: development of MPMV packaging cell linesF M Guesdon, J Greatorex, S R Rhee, et al.

Blood|May 1, 1997

Variable immortalizing potential and frequent virus latency in blood-derived T-cell clones infected with human T-cell leukemia virus type IJ H Richardson, P Höllsberg, A Windhagen, et al.

Journal of Medical Virology|January 1, 1988

Presence of a partially acid-labile alpha-interferon in bronchoalveolar lavage fluid of patients with cytomegalovirus pneumonitis is associated with a poor prognosisA M Lever, H J Milburn, R M du Bois, et al.

Alimentary Pharmacology & Therapeutics|August 1, 1987

Human lymphoblastoid interferon does not increase survival when added to mitozantrone in the treatment of hepatocellular carcinomasM G Brook, A A Dunk, J A McDonald, et al.

Annals of the Rheumatic Diseases|November 1, 1994

Polymerase chain reaction fails to incriminate exogenous retroviruses HTLV-I and HIV-1 in rheumatological diseases although a minority of sera cross react with retroviral antigensP N Nelson, A M Lever, F E Bruckner, et al.

Clinical and Experimental Immunology|July 1, 1985

Defective low-density cells of dendritic morphology from the blood of patients with common variable hypogammaglobulinaemia: low immunoglobulin production on stimulation of normal B cellsJ Farrant, A E Bryant, A M Lever, et al.

The Quarterly Journal of Medicine|April 1, 1989

Antenatal screening for hepatitis B is medically and economically effective in the prevention of vertical transmission: three years experience in a London hospitalM G Brook, A M Lever, D Kelly, et al.

Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:

Pageof 7

Clinical and Experimental Immunology|February 1, 1987

Increased half-life of gammaglobulin after prolonged intravenous replacement therapyA M Lever, P L Yap, B Cuthbertson, et al.

Infection|January 1, 1987

A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies of hepatitis B virus carrier treatment: identification of factors influencing response ratesH C Thomas, L J Scully, A M Lever, et al.

Journal of Virological Methods|April 20, 2001

Chromosomal positioning of human T-lymphotropic type 1 proviruses by fluorescence in situ hybridisationJ H Richardson, N J Rose, S Mann, et al.

Virology|September 7, 2001

Sequences in the 5' leader of Mason-Pfizer monkey virus which affect viral particle production and genomic RNA packaging: development of MPMV packaging cell linesF M Guesdon, J Greatorex, S R Rhee, et al.

Blood|May 1, 1997

Variable immortalizing potential and frequent virus latency in blood-derived T-cell clones infected with human T-cell leukemia virus type IJ H Richardson, P Höllsberg, A Windhagen, et al.

Journal of Medical Virology|January 1, 1988

Presence of a partially acid-labile alpha-interferon in bronchoalveolar lavage fluid of patients with cytomegalovirus pneumonitis is associated with a poor prognosisA M Lever, H J Milburn, R M du Bois, et al.

Alimentary Pharmacology & Therapeutics|August 1, 1987

Human lymphoblastoid interferon does not increase survival when added to mitozantrone in the treatment of hepatocellular carcinomasM G Brook, A A Dunk, J A McDonald, et al.

Annals of the Rheumatic Diseases|November 1, 1994

Polymerase chain reaction fails to incriminate exogenous retroviruses HTLV-I and HIV-1 in rheumatological diseases although a minority of sera cross react with retroviral antigensP N Nelson, A M Lever, F E Bruckner, et al.

Clinical and Experimental Immunology|July 1, 1985

Defective low-density cells of dendritic morphology from the blood of patients with common variable hypogammaglobulinaemia: low immunoglobulin production on stimulation of normal B cellsJ Farrant, A E Bryant, A M Lever, et al.

The Quarterly Journal of Medicine|April 1, 1989

Antenatal screening for hepatitis B is medically and economically effective in the prevention of vertical transmission: three years experience in a London hospitalM G Brook, A M Lever, D Kelly, et al.

Pageof 7